In 4897 patients after drug-eluting stent PCI in South Korea, 1-month DAPT failed non-inferiority to 3-month in high bleeding risk patients (net adverse events 18.4% vs 14.0%); in others, 3-month was non-inferior to 12-month and caused less bleeding (7.4% vs 11.7%).
RCTn = 4,897
Kang et al. Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trial